Arabino-mycolates derived from cell-wall skeleton of Mycobacterium bovis BCG as a prominent structure for recognition by host immunity

Drug Discoveries & Therapeutics

Volumn 5, Issue 3, 2011, Pages 130-135

  Miyauchi, Masanori ^a   Uenishi, Yuko ^a   Yano, Ikuya ^b   Murata, Masashi ^a   Sunagawa, Makoto ^a   Shibuya, Keiko ^a   Koga Yamakawa, Erina ^a   Kusunose, Naoto ^a   Kashiwazaki, Yasuo ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^b Kiyose   (Japan)

Author keywords

Arabino mycolates; BCG CWS; SMP 105; TLR2

Indexed keywords

EID: 85008750409     PISSN: 18817831     EISSN: 1881784X     Source Type: Journal    
DOI: 10.5582/ddt.2011.v5.3.130     Document Type: Article

References (31)

1. Kodama K, Higashiyama M, Takami K, Oda K, Okami J, Maeda J, Akazawa T, Matsumoto M, Seya T, Wada M, Toyoshima K. Innate immune therapy with a Bacillus Calmette-Guerin cell wall skeleton after radical surgery for non-small cell lung cancer: A case-control study. Surg Today. 2009; 39:194-200.
2. Azuma I, Ribi EE, Meyer TJ, Zbar B. Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3. J Natl Cancer Inst. 1974; 52:95-101.
3. Matsumoto M, Seya T, Kikkawa S, et al. Interferon gamma-producing ability in blood lymphocytes of patients with lung cancer through activation of the innate immune system by BCG cell wall skeleton. Int Immunopharmacol. 2001; 1:1559-1569.
4. Hayashi D, Takii T, Fujiwara N, Fujita Y, Yano I, Yamamoto S, Kondo M, Yasuda E, Inagaki E, Kanai K, Fujiwara A, Kawarazaki A, Chiba T, Onozaki K. Comparable studies of immunostimulating activities in vitro among Mycobacterium bovis bacillus Calmette-Guerin (BCG) substrains. FEMS Immunol Med Microbiol. 2009; 56:116-128.
5. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006; 124:783-801.
6. Medzhitov R, Janeway CA, Jr. Innate immunity: The virtues of a nonclonal system of recognition. Cell. 1997; 91:295-298.
7. Tsuji S, Matsumoto M, Takeuchi O, Akira S, Azuma I, Hayashi A, Toyoshima K, Seya T. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: Involvement of toll-like receptors. Infect Immun. 2000; 68:6883-6890.
8. Murata M. Activation of Toll-like receptor 2 by a novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors. Cancer Sci. 2008; 99:1435-1440.
9. Brennan PJ. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis (Edinb). 2003; 83:91-97.
10. Ishiwata A, Akao H, Ito Y, Sunagawa M, Kusunose N, Kashiwazaki Y. Synthesis and TNF-alpha inducing activities of mycoloyl-arabinan motif of mycobacterial cell wall components. Bioorg Med Chem. 2006; 14:3049-3061.
11. Takimoto H, Maruyama H, Shimada KI, Yakabe R, Yano I, Kumazawa Y. Interferon-gamma independent formation of pulmonary granuloma in mice by injections with trehalose dimycolate (cord factor), lipoarabinomannan and phosphatidylinositol mannosides isolated from Mycobacterium tuberculosis. Clin Exp Immunol. 2006; 144:134-141.
12. Sakaguchi I, Ikeda N, Nakayama M, Kato Y, Yano I, Kaneda K. Trehalose 6,6'-dimycolate (Cord factor) enhances neovascularization through vascular endothelial growth factor production by neutrophils and macrophages. Infect Immun. 2000; 68:2043-2052.
13. Grand-Perret T, Lepoivre M, Petit JF, Lemaire G. Macrophage activation by trehalose dimycolate requirement for an expression signal in vitro for antitumoral activity; biochemical markers distinguishing primed and fully activated macrophages. Eur J Immunol. 1986; 16:332-338.
14. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol. 1999; 163:3920-3927.
15. Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M, Aderem A. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature. 1999; 401:811-815.
16. Uenishi Y, Kusunose N, Yano I, Sunagawa M. Isolation and identification of arabinose mycolates of cell wall skeleton (CWS) derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105). J Microbiol Methods. 2010; 80:302-305.
17. Miyauchi M, Murata M, Shibuya K, Koga-Yamakawa E, Yanagawa Y, Azuma I, Kashiwazaki Y. Phagocytosis plays a dual role in activating dendritic cells; digestive production of active Toll-like receptor ligands and cooperation with Toll-like receptor signaling. Drug Discov Ther. 2010; 4:135-143.
18. Uenishi Y, Okada T, Okabe S, Sunagawa M. Study on the cell wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105): Establishment of preparation and analytical methods. Chem Pharm Bull (Tokyo). 2007; 55:843-582.
19. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. Cutting edge: Repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J Immunol. 2000; 165:618-622.
20. Manthey CL, Perera PY, Henricson BE, Hamilton TA, Qureshi N, Vogel SN. Endotoxin-induced early gene expression in C3H/HeJ (Lpsd) macrophages. J Immunol. 1994; 153:2653-2663.
21. Manthey C, Vogel S. Elimination of trace endotoxin protein from rough chemotype LPS. J Endotoxin Res. 1994; 1:84-91.
22. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 1999; 11:443-451.
23. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol. 1999; 162:3749-3752.
24. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 1999; 11:115-122.
25. Werninghaus K, Babiak A, Gross O, et al. Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRγ-Syk-Card9-dependent innate immune activation. J Exp Med. 2009; 206:89-97.
26. Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik SG, Lee H, Lee JO. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell. 2007; 130:1071-1082.
27. Gavin AL, Hoebe K, Duong B, Ota T, Martin C, Beutler B, Nemazee D. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science. 2006; 314:1936-1938.
28. Geisel RE, Sakamoto K, Russell DG, Rhoades ER. In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guerin is due principally to trehalose mycolates. J Immunol. 2005; 174:5007-5015.
29. Agger EM, Rosenkrands I, Hansen J, Brahimi K, Vandahl BS, Aagaard C, Werninghaus K, Kirschning C, Lang R, Christensen D, Theisen M, Follmann F, Andersen P. Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): A versatile adjuvant for vaccines with different immunological requirements. PLoS One. 2008; 3:e3116.
30. Ishikawa E, Ishikawa T, Morita YS, Toyonaga K, Yamada H, Takeuchi O, Kinoshita T, Akira S, Yoshikai Y, Yamasaki S. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J Exp Med. 2009; 206:2879-2888.
31. Koike Y, Yoo YC, Mitobe M, Oka T, Okuma K, Tono-oka S, Azuma I. Enhancing activity of mycobacterial cell-derived adjuvants on immunogenicity of recombinant human hepatitis B virus vaccine. Vaccine. 1998; 16:1982-1989.